Skip to main content
. Author manuscript; available in PMC: 2015 May 30.
Published in final edited form as: Vaccine. 2014 Apr 13;32(26):3187–3197. doi: 10.1016/j.vaccine.2014.04.002

Table 2.

Clinical course of infection in NHPs inoculated with WNV, WN/DEN4Δ30, DEN4Δ30, or YF 17D

Inoculum Clinical signsa Clinical course on indicated dpi
0–3 4 5 6 7 8 9/10 14 21
WNV Gradeb 0
100%
2
22%
2
22%
3
33%
3
56%
3
83%
4
100%
N/A N/A
Temperaturec 39.9°C
25%
40.8°C
56%
40.7°C
78%
40.8°C
50%
N/A N/A
WN/DEN4Δ30 Grade 0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
Temperature 39.4°C
27%
39.7°C
33%
39.7°C
22%
DEN4Δ30 Grade 0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
Temperature 39.6°C
8%
40.4°C
78%
YF 17D Grade 0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
0
100%
Temperature 39.8°C
25%
39.6°C
11%
39.8°C
22%
40.2°C
67%
a

Clinical signs were monitored and recorded as described in the Materials and Methods.

b

Neurological grades and percent of animals having the corresponding grade are shown.

c

If temperature was elevated (>39.3°C), the maximum recorded temperature and percent of animals with febrile reaction are shown. N/A – not applicable (all WNV-infected monkeys were euthanized at 9/10 dpi). Mock-inoculated animals (not shown) remained normal during the entire experiment (neurological grade 0; normal temperature).